| CTRI Number |
CTRI/2025/04/084490 [Registered on: 09/04/2025] Trial Registered Prospectively |
| Last Modified On: |
08/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device Dentistry |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A Novel Approach For Maxillary Advancement |
|
Scientific Title of Study
|
COMPARISON OF SKELETAL DENTAL AND SOFT TISSUE CHANGES IN GROWING SKELETAL CLASS III INDIVIDUALS USING FACEMASK WITH RME VS CUSTOMISED MINI PLATES - A RANDOMISED CONTROLLED TRIAL |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Nataleya Felix |
| Designation |
Post Graduate |
| Affiliation |
Saveetha Dental College and Hospitals |
| Address |
No.169, Saveetha Dental College and Hospital, Poonamallee High
Road, Velappanchavadi, Chennai.
Thiruvallur
TAMIL NADU
600077
India
Chennai TAMIL NADU 600077 India |
| Phone |
7904989610 |
| Fax |
|
| Email |
152308007.sdc@saveetha.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Srirengalakshmi Muthuswamy Pandian |
| Designation |
Associate Professor |
| Affiliation |
Saveetha Dental College and Hospitals |
| Address |
No.169, Saveetha Dental College and Hospital, Poonamallee High
Road, Velappanchavadi, Chennai.
Thiruvallur
TAMIL NADU
600077
India
Chennai TAMIL NADU 600077 India |
| Phone |
8867783552 |
| Fax |
|
| Email |
rengalakshmi1910@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Nataleya Felix |
| Designation |
Post Graduate |
| Affiliation |
Saveetha Dental College and Hospitals |
| Address |
No.169, Saveetha Dental College and Hospital, Poonamallee High
Road, Velappanchavadi, Chennai.
Thiruvallur
TAMIL NADU
600077
India
Chennai TAMIL NADU 600077 India |
| Phone |
7904989610 |
| Fax |
|
| Email |
152308007.sdc@saveetha.com |
|
|
Source of Monetary or Material Support
|
| Saveetha Dental College and Hospitals
No 162, Poonamallee High Road Velappanchavadi
Chennai 600077 |
|
|
Primary Sponsor
|
| Name |
L Felix Reginald |
| Address |
194/77 Addis Street, Grey Town, Uppilipalayam
Coimbatore 641018 |
| Type of Sponsor |
Other [Labour Officer] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Nataleya Felix |
Saveetha Dental College and Hospitals |
Clinic 27, Fifth floor, Department of Orthodontics Chennai TAMIL NADU |
7904989610
152308007.sdc@saveetha.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Human Ethical Committee (SDC-IHEC) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: 4||Measurement and Monitoring, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Bonded RME with Facemask |
Bonded RME with conventional facemask will be used |
| Intervention |
Maxi Pro Bone Plates |
MaxiPro Bone plates are used in Skeletal Class III Growing patients with maxillary hypoplasia to protract the maxillary bone and to improve the facial appearance at an early age to avoid surgical treatment |
|
|
Inclusion Criteria
|
| Age From |
8.00 Year(s) |
| Age To |
13.00 Year(s) |
| Gender |
Both |
| Details |
Skeletal Class III patients with maxillary hypoplasia
growing patients |
|
| ExclusionCriteria |
| Details |
Growing children with Skeletal class II due to prognathic mandible
Adults with Skeletal class III malocclusion |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Skeletal, Dental, Soft tissue changes |
6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Airway changes |
6 months |
|
|
Target Sample Size
|
Total Sample Size="7" Sample Size from India="7"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/05/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [rengalakshmi1910@gmail.com].
- For how long will this data be available start date provided 01-01-2026 and end date provided 31-12-2028?
Response - Beginning 9 months and ending 36 months following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - Nil
|
|
Brief Summary
|
none |